FDA withdraws Covid antibody treatment Evusheld because it's not effective against 93% of subvariants

Upworthy

27 Jan 2023 0 shares 1 views

FDA withdraws Covid antibody treatment Evusheld because it's not effective against 93% of subvariants

Upworthy

Published 27 Jan 2023

injection, a new COVID-19 treatment that people can take before becoming symptomatic. (Chris Sweda/Chicago Tribune/Tribune News Service via Getty Images) The Food and Drug Administration on Thursday pulled its authorization for AstraZeneca 's Evusheld, an antibody injection that people with weak…

#astrazeneca #evusheld #fda #xbb #cdc #ashishjha

Full Article

FDA withdraws emergency use authorization of COVID drug because it is unlikely to be effective against new variants

Upworthy 28 Jan 2023

The U.S. Food and Drug Administration said Thursday it is withdrawing its emergency use authorization of a COVID-19 antibody..

FDA pulls authorization for COVID antibody treatment over lack of effectiveness
Upworthy 27 Jan 2023
FDA pulls COVID-19 antibody treatment's emergency authorization
PIX 11 27 Jan 2023

FDA withdraws Covid antibody treatment Evusheld because it's not effective against 93% of subvariants

FDA withdraws Covid antibody treatment Evusheld because it's not effective against 93% of subvariants

You might like

Related news coverage

FDA withdraws emergency use authorization of COVID drug because it is unlikely to be effective against new variants

Advertisement